Cargando…
Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease
Inflammatory bowel disease (IBD), a term used for Crohn’s disease and ulcerative colitis that are characterized by chronic inflammation of the gastrointestinal tract, has been suggested to be closely related to high risk of developing colorectal or gastric cancer [1]. Focusing on patient cases and s...
Autor principal: | Jones, Ryan Lane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052348/ https://www.ncbi.nlm.nih.gov/pubmed/35506038 http://dx.doi.org/10.5114/wo.2022.114537 |
Ejemplares similares
-
Metabolic Phenotypes as Potential Biomarkers for Linking Gut Microbiome With Inflammatory Bowel Diseases
por: Iablokov, Stanislav N., et al.
Publicado: (2021) -
Inflammatory bowel disease biomarkers revealed by the human gut microbiome network
por: Hu, Mirko, et al.
Publicado: (2023) -
Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
por: Olendzki, Barbara, et al.
Publicado: (2022) -
Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
por: Guo, Xue, et al.
Publicado: (2022) -
Vitamin D, the gut microbiome and inflammatory bowel disease
por: Tabatabaeizadeh, Seyed-Amir, et al.
Publicado: (2018)